Background. High-level physical activity is associated with lower colorectal cancer (CRC) mortality, likely through insulin sensitization. Insulin receptor substrate 1 (IRS1) is a mediator of insulin and insulin-like growth factor (IGF) signaling pathways, and its down-regulation is associated with insulin resistance. Therefore, we hypothesized that tumor IRS1 expression status might modify cellular sensitivity to insulin and IGF, and the prognostic association of physical activity. Methods. We assessed IRS1 expression level in 371 stage I-III rectal and colon cancers in the Nurses' Health Study and the Health Professionals Follow-up Study by immunohistochemistry. In survival analysis, Cox proportional hazards model was used to assess an interaction between post-diagnosis physical activity (ordinal scale of sex-specific quartiles Q1 to Q4) and IRS1 expression (ordinal scale of negative, low, and high), controlling for potential confounders, including microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element-1 (LINE-1) methylation level, and KRAS, BRAF, and PIK3CA mutation status.
Conclusions. The association of post-diagnosis physical activity with colorectal carcinoma patient survival may differ by tumor IRS1 expression level. If validated, tumor IRS1 expression status may serve as a predictive marker to identify subgroups of patients who might gain greater survival benefit from an increased level of exercise.
Colorectal cancer (CRC) is a leading cause of cancer death worldwide, and its complex, heterogeneous etiology has not been fully elucidated. Insulin resistance may be causally linked to CRC incidence 1-8 and cancer survival, 9 ,10 whereas, physical activity may reduce CRC risk [11] [12] [13] [14] [15] [16] [17] and mortality. [18] [19] [20] [21] [22] [23] Although the underlying mechanism remains uncertain, accumulating evidence suggests that physical activity may influence CRC patient survival by increasing insulin sensitivity. 24, 25 Insulin receptor substrate 1 (IRS1), the HUGO-approved official symbol (HUGO Gene Nomenclature Committee [HGNC] ID: 6215) is a cytoplasmic substrate of the insulin receptor (INSR) and insulin-like growth factor 1 receptor (IGF1R) signaling pathways. [26] [27] [28] IRS1 mediates glucose homeostasis, 29, 30 as well as the proliferative and antiapoptotic function of insulin and IGF1 by transmitting signals from the activated receptors to downstream effectors. 31 IRS1 also plays prominent roles in human malignancy and is activated in various human cancers, including CRC. 26, 27, [32] [33] [34] [35] [36] [37] Considering the possible effect of physical activity on insulin sensitization, and the roles of IRS1 in insulin resistance, we hypothesized that the tumor IRS1 expression level might influence the prognostic association of postdiagnosis physical activity with patient survival in CRC. To test this hypothesis, we designed a molecular pathological epidemiology (MPE) study to assess the statistical interaction between post-diagnosis physical activity and tumor IRS1 expression levels in analysis of CRC-specific survival, controlling for major tumor molecular features, including microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS, BRAF, and PIK3CA mutations.
MATERIALS AND METHODS

Study Population and Ascertainment of Cases
We used two US nationwide prospective cohort studies-the Nurses' Health Study (NHS; N = 121,701 women observed since 1976) and the Health Professionals FollowUp Study (HPFS; N = 51,529 men observed since 1986). 38, 39 Collection of clinical information and tumor tissue is described in the electronic supplementary material. Written informed consent was obtained from all study participants, and tissue collection and analyses were approved by the Human Subjects Committees at Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital.
A total of 371 stage I-III CRC cases diagnosed by 2008 were included in this study based on the availability of tissue, IRS1 expression data, and post-diagnosis physical activity data (Fig. 1) . Cases of stage IV CRCs were excluded from the analyses to minimize bias related to differential reporting of physical activity data according to severity of disease. 40 Patients were observed until death or January 2012, whichever came first. Death was ascertained by use of the National Death Index. Study physicians, unaware of exposure information, reviewed medical and FIG. 1 Case selection process. Among the incident cases of CRC, those with one or more of the followings were excluded from this study: no available cancer tissue, stage IV, no tissue in tissue microarray or valid IRS1 data, or no information of post-diagnosis physical activity. CRC colorectal cancer, HPFS Health Professionals Follow-up Study, NHS Nurses' Health Study, TMA tissue microarray, IRS1 insulin receptor substrate 1 pathological records to retrieve information on tumor location and disease stage.
Assessment of Physical Activity
Leisure-time physical activity was evaluated every 2 years, and validated against physical activity diaries. 41 Participants reported the duration of physical activity (ranging from 0 to 11 or more hours/week) engaged in walking at usual pace, jogging, running, cycling, swimming laps, racket sports, other aerobic exercises, lower intensity exercise (yoga, toning, stretching), or other vigorous activities. 41 Each activity on the questionnaire was assigned a metabolic equivalent task score (METS). METS is defined as the ratio of the metabolic rate of specific activities to the resting metabolic rate; one METS is the energy expenditure for sitting quietly. 42, 43 The METS from the individual activities were summed to yield a total METS hours/week. To avoid the period of active anticancer treatment, the first assessment of postdiagnosis physical activity was conducted between 1 and 4 years after the diagnosis of CRC (median 17 months). 41 To minimize bias due to declining physical activity in the period around cancer recurrence or death, physical activity was assessed at a single point of time after the diagnosis of CRC and not updated thereafter. 20, 40 To minimize bias associated with occult cancer recurrence, we excluded deaths within 6 months of the activity assessment.
We classified post-diagnosis physical activity level (METS/week) into sex-specific quartiles (Q1, the lowest, to Q4, the highest), considering that the distribution of physical activity level considerably differed between men and women. 42, 44 We primarily used a combined cohort of men and women to maximize statistical power. As a secondary analysis, we examined the relation between postdiagnosis physical activity and patient survival in strata of tumor IRS1 expression level (negative, low, or high) in each cohort, and confirmed consistency in results between men and women. [48] [49] [50] and long interspersed nucleotide element-1 (LINE-1) methylation 51, 52 (see electronic supplementary material).
Immunohistochemistry
Tissue microarray was constructed as described. 38 Immunostaining methods for CTNNB1 (b-catenin), 53 
TP
53,54 and PTGS2 (cyclooxygenase-2 [COX-2]) 55 were previously described. IRS1 and IRS2 immunostaining procedures are described in the electronic supplementary material. Cytoplasmic IRS1 and IRS2 expression status were classified as negative, low, or high (Fig. 2) .
IRS1 and IRS2 expression levels in all cases were interpreted by a pathologist (T.M.), and a random group of 122 cases was independently reviewed by a second pathologist (S.A.K.). Both pathologists were unaware of other data. Concordance between the two pathologists indicated substantial agreement for both IRS1 status (three levels) [weighted j = 0.69; p \ 0.001] and IRS2 status (three levels) [weighted j = 0.77; p \ 0.001].
Statistical Analysis
Detailed statistical methodologies are described in the electronic supplementary material. All statistical analyses were conducted using SAS software, version 9.3 (SAS Institute, Cary, NC, USA). All p-values were two-sided. Our primary hypothesis testing was assessment of the interaction between post-diagnosis physical activity and tumor IRS1 expression level in CRC-specific survival analysis in the combined cohort. All other analyses and hypothesis testing in this study were secondary analyses, and therefore results were interpreted cautiously. In particular, we were aware of multiple testing inherent in the subgroup analyses of prognostic associations of physical activity in strata of the IRS1 status. To test differences in the frequency distribution of categorical data, the v 2 test was performed, and one-way analysis of variance (ANOVA) was used to compare mean age and mean LINE-1 methylation level.
For the primary endpoint CRC-specific survival, participants were censored at the time of death if death was not due to CRC. Multivariable Cox proportional hazards regression models were used to control for potential confounders, and were stratified by stage and sex to limit the number of variables in multivariable models. A statistical interaction was assessed by a likelihood ratio test, using the cross-product of post-diagnosis physical activity (ordinal variable of four categories: Q1, Q2, Q3, and Q4) and IRS1 status (three ordinal categories of negative, low, and high level) as the interaction term. P interaction value was calculated by comparing the model with the interaction term with the model without the interaction term. We used an initial model including the interaction term, post-diagnosis physical activity, tumor IRS1 status, and other possible covariates, and conducted a backward elimination procedure.
In addition to regression models for the interaction term, in our secondary analysis, we calculated survival hazard ratio (HR) for high post-diagnosis physical activity (vs. low activity) in each stratum of IRS1 expression level (negative, low, or high). We divided post-diagnosis physical activity into two categories (Q1-Q2 as low level, and Q3-Q4 as high level).
Combined categories of disease stage (I, II, III, missing) and sex were used as a stratifying variable using the 'strata' option in the SAS 'proc phreg' command to minimize residual confounding and overfitting. The proportionality of hazards assumption was evaluated using a time-dependent variable, which was a cross-product of the IRS1 variable and survival time (all p-values [0.20).
RESULTS
Frequency of clinical, pathologic, and molecular features of the 371 stage I-III CRCs included in this study are summarized in Table 1 (the features in each cohort are shown in electronic supplementary Tables S1 and S2) according to post-diagnosis physical activity quartiles. There was no significant association between tumor IRS1 expression status and post-diagnosis physical activity in both cohorts.
During follow-up of CRC patients (with a median of 15.1 years), there were 168 deaths, including 52 CRCspecific deaths. Tumor IRS1 expression status was not significantly associated with either CRC-specific or overall survival in univariable or multivariable analysis (Table 2) .
Our primary aim was to examine an interaction between post-diagnosis physical activity level and tumor IRS1 expression in CRC-specific survival analysis. There was a significant interaction between post-diagnosis physical activity and IRS1 expression status in univariable and multivariable CRC-specific survival analyses (P interaction = 0.005 in both analyses) ( Table 3 ). In each stratum of IRS1 expression level, we calculated survival HR for high post-diagnosis physical activity (Q3-Q4 vs. Q1-Q2). In multivariable analyses, CRC-specific survival HR (95 % confidence interval [CI]) for high post-diagnosis physical activity (vs. low activity) was 0.15 (0.02-1.38) in IRS1-negative CRC, 0.45 (0.19-1.03) in IRS1-low CRC, and 1.32 (0.50-3.53) in IRS1-high CRC. In a combined group of the IRS1-negative and IRS1-low strata, CRC-specific survival HR (95 % CI) for high post-diagnosis physical activity was 0.39 (0.17-0.82) ( Table 3) . As an exploratory survival analysis, we examined an interaction between post-diagnosis physical activity level and tumor IRS1 expression among colon cancer cases (electronic supplementary Table S3 ). Similar to the results using all CRC cases, we demonstrated a statistically significant interaction between post-diagnosis physical activity and IRS1 expression level in colon-cancer-specific survival analysis. (22) 21 (23) 25 (28) 14 (15) 23 (25) Tumor location 0.18 Caecum 70 (19) 17 (19) 14 (15) 20 (22) 19 (20) Ascending and transverse colon 102 (28) 23 (25) 24 (26) 31 (33) 24 (26) Splenic flexure to sigmoid colon 117 (32) 25 (28) 33 (36) 25 (27) 34 (36) Rectum 80 (22) 26 (29) 20 (22) 17 (18) 17 (18) Cancer (42) 38 (40) 38 (41) CIMP-high 54 (15) 16 (18) 10 (11) 17 (18) 11 (12) LINE-1 methylation, % (mean ± SD) 60.9 ± 9.7 60.0 ± 10.6 59.1 ± 9.4 61. In each cohort, we examined CRC-specific survival HR for high post-diagnosis physical activity (Q3-Q4 vs. Q1-Q2) in strata of IRS1 expression level, and confirmed that results were generally consistent between men and women, although statistical power was limited (electronic supplementary Table S4) . Table S5 shows survival HR for a one-category increase in physical activity quartiles, in strata of IRS1 expression level, in men, women, and a combined cohort. CRC-specific survival HR for a onequartile increase in post-diagnosis physical activity became (60) 57 (63) 64 (70) 46 (48) 54 (58) High 116 (31) 28 (31) 19 (21) 38 (40) 31 (33) IRS2 expression 0.22
Electronic supplementary
Negative 28 (7.9) 6 (7.1) 10 (11) 9 (9.7) 3 (3.4) Low 207 (58) 50 (59) 55 (62) 51 (55) 51 (58) High 120 (34) 29 (34) 24 (27) 33 (35) 34 (39) Data are expressed as n (%) unless otherwise specified CI confidence interval, HR hazard ratio, IRS1 insulin receptor substrate 1 a Combined categories of disease stage (I, II, III, missing) and sex were used as a stratifying variable. Selection of covariates included in the final model is described in the Materials and Methods section b P trend values were calculated using IRS1 expression levels as an ordinal categorical variable in a proportional hazards model consistently higher for a higher category of tumor IRS1 expression status. Because our previous studies showed that the association of post-diagnosis physical activity with survival of CRC patients differed by status of tumor CTNNB1 56 or PTGS2 (cyclooxygenase-2) 42 expression, we performed secondary analyses stratified by combined IRS1 and CTNNB1 (electronic supplementary Table S6 ), and by combined IRS1 and PTGS2 status (electronic supplementary Table S7 ). Although statistical power was limited, we observed a trend toward lower CRC-specific survival HR (for high physical activity level vs. low activity) in the combined IRS1-negative and IRS1-low CRC group, compared with IRS1-high CRC, and this trend did not appear to be appreciably altered by CTNNB1 and PTGS2 status.
As secondary analyses, we examined the interaction between post-diagnosis physical activity and tumor expression of IRS2 (another cytoplasmic substrate of the INSR and IGF1R signaling pathways). There was no significant interaction between post-diagnosis physical activity and IRS2 expression status in CRC-specific survival analysis (P interaction = 0.15) and overall survival analysis (P interaction = 0.94). In addition, tumor IRS2 expression status was not significantly associated with CRC-specific survival in univariable or multivariable analysis (P trend [ 0.20) (electronic supplementary Table S8 ).
DISCUSSION
We tested the hypothesis that the prognostic association of post-diagnosis physical activity with CRC survival might differ by IRS1 expression level. To our knowledge, this is the first study to evaluate the interactive role of IRS1 expression and physical activity on survival in patients with CRC. We found a statistically significant interaction between post-diagnosis physical activity and IRS1 expression level in CRC-specific survival analysis. Our data suggest that tumor IRS1 expression status can identify individuals who may particularly benefit from exercise.
Given the generally harmless nature of most exercise activities, it may be recommended that CRC patients engage in physical activity regardless of tumor biomarker data. [18] [19] [20] [21] [22] [23] Nonetheless, our current analysis represents a valuable hypothesis-generating study, which can inform future studies to elucidate the mechanism and develop CRC prevention and treatment strategies targeting the insulin and IGF1 signaling pathway.
Insulin-resistance states contribute to higher CRC incidence and mortality. [8] [9] [10] 57 One possible reason may arise in that exercise improves systemic insulin sensitivity and decreases blood insulin level, leading to prevention of CRC incidence and death. 24, 26, 57 Our human population-based data, along with these lines of experimental evidence, With a backward stepwise elimination with a threshold of p = 0.05, selected covariates in the final model were 'year of CRC diagnosis (continuous)' for CRC-specific survival analysis, and 'age at diagnosis (continuous)' and 'tumor location (caecum vs. ascending to transverse vs. splenic flexure to sigmoid vs. rectum)' for overall survival analysis c P interaction value (two-sided) was calculated using the likelihood ratio test which compared the model with the interaction term with the model without the interaction term. The interaction term represents the cross-product of post-diagnosis physical activity (four ordinal categories from Q1 to Q4) and IRS1 expression level (three ordinal categories from negative to high expression) support the hypothesis that the prognostic association of post-diagnosis physical activity may differ by tumor IRS1 expression level, although further studies are needed to clarify the exact mechanism. Integrative analysis of lifestyle factors and tumor characteristics is increasingly important [58] [59] [60] [61] [62] [63] [64] because those factors contribute to the heterogeneity of the tumor. 65, 66 As previously shown, the association between post-diagnosis physical activity and CRC-specific survival might differ by tumor CTNNB1 56 or PTGS2 42 expression status. In our secondary analysis, the association between physical activity and survival appeared to be stronger in patients with IRS1-negative/low CRCs than in those with IRS1-high CRC, irrespective of CTNNB1 and PTGS2 status, although statistical power was limited. Further large-scale studies should assess tumor IRS1 status, together with other markers, as potential predictive biomarkers for benefit from exercise.
We observed no interaction between post-diagnosis physical activity and tumor IRS2 expression. Although both IRS1 and IRS2 are involved in insulin-related metabolism, they have different tissue-specific function. [67] [68] [69] IRS1 is mainly associated with insulin resistance in skeletal muscle, while IRS2 is mainly involved in insulin resistance and lipid metabolism in liver. 67, 69 Similarly, our results may be consistent with differential functions of IRS1 and IRS2 in CRC cells in relation to exercise-induced change of the tumor microenvironment.
There are strengths in this study. Extensive epidemiologic and molecular characterization of our cohorts enabled us to examine interactive effects of a specific lifestyle factor in relation to tumor characteristics. This MPE approach can link exposures to specific molecular pathologic signatures, give clues to mechanisms, enhance causal inference, and identify potential biomarkers for clinical use. [70] [71] [72] [73] [74] [75] Study participants were distributed throughout the US and, in general, represent CRC cases in the US population. Data on lifestyle and tumors were collected prospectively by investigators blinded to patient outcomes.
Limitations of our study include the lack of treatment information after the diagnosis of CRC. However, due to the unaware of molecular data on physicians, it was unlikely that chemotherapy use substantially differed according to IRS1 status. Second, information on cancer recurrence was not available, but with long follow-up on censored cases, CRC-specific mortality is a reasonable proxy for CRCspecific outcomes. Third, the possibility of reverse causation cannot be excluded. Nonetheless, reverse causation may not be the sole explanation to the observed interaction between tumor IRS1 expression status and post-diagnosis physical activity. Fourth, the likelihood of return of the physical activity assessment may be higher among patients who were relatively healthier. Thus, we limited our study to stage I-III cases in order to minimize effect of this selection bias in an attempt to retain statistical power. Lastly, our overall sample size and statistical power were such that the results require validation in independent studies.
CONCLUSIONS
The positive association of post-diagnosis physical activity with CRC patient survival may be stronger for tumors with IRS1-negative/low expression than for tumors with IRS1-high expression. These findings need to be validated in additional populations. Upon validation, tumor IRS1 expression status may serve as a potential biomarker to identify subgroups of CRC patients who might gain greater survival benefit from an increased level of exercise.
